Quantifying the impact of differing measures used to study persistence and adherence with the infusible anti-inflammatory biologic infliximab- Utilization from real-world medical practice
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.600
https://www.valueinhealthjournal.com/article/S1098-3015(13)00671-2/fulltext
Section Title :
Systemic Disorders/Conditions
Section Order :
148
First Page :
A124
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00671-2&doi=10.1016/j.jval.2013.03.600